A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

by | Sep 30, 2025 | Clinical Trials | 0 comments

​ Conditions: Cytomegalovirus Prophylaxis

Interventions: Drug: Letermovir

Sponsors: Merck Sharp & Dohme LLC

Not yet recruiting Conditions: Cytomegalovirus Prophylaxis
Interventions: Drug: Letermovir
Sponsors: Merck Sharp & Dohme LLC
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *